par Criscitiello, Carmen ;Metzger-Filho, Otto;Saini, Kamal ;de Castro, Gilberto;Diaz, Marie;La Gerche, André;de Azambuja, Evandro ;Piccart-Gebhart, Martine
Référence Breast cancer research, 14, 3, page (209)
Publication Publié, 2012
Référence Breast cancer research, 14, 3, page (209)
Publication Publié, 2012
Article révisé par les pairs
Titre: |
|
Auteur: | Criscitiello, Carmen; Metzger-Filho, Otto; Saini, Kamal; de Castro, Gilberto; Diaz, Marie; La Gerche, André; de Azambuja, Evandro; Piccart-Gebhart, Martine |
Informations sur la publication: | Breast cancer research, 14, 3, page (209) |
Statut de publication: | Publié, 2012 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Angiogenesis Inhibitors -- adverse effects |
Antibodies, Monoclonal, Humanized -- adverse effects | |
Antineoplastic Agents -- adverse effects | |
Breast Neoplasms -- drug therapy -- genetics | |
Female | |
Heart Failure -- chemically induced | |
Humans | |
Molecular Targeted Therapy -- adverse effects | |
Quinazolines -- adverse effects | |
Ventricular Dysfunction, Left -- chemically induced | |
Note générale: | Journal Article |
Review | |
SCOPUS: re.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:1465-5411 |
info:doi/10.1186/bcr3142 | |
info:pii/bcr3142 | |
info:scp/84862487751 | |
info:pmid/22713170 | |
PMC3446327 |